Wegovy Alternatives in District of Columbia
Compare generic and therapeutic alternatives to Wegovy (semaglutide (2.4 mg)) available at District of Columbia pharmacies. Save up to 35% on your prescription — no insurance required.
Top Alternatives in District of Columbia
Zepbound (tirzepatide)
therapeutic
GIP/GLP-1 dual agonist — showed greater average weight loss in trials
Avg cash price: $1060/mo
Ozempic (lower-dose semaglutide)
therapeutic
Same molecule, prescribed off-label for weight loss at lower doses
Avg cash price: $940/mo
Compounded semaglutide
therapeutic
Compounding pharmacy alternative during FDA shortage periods
Avg cash price: $280/mo
District of Columbia Prescription Assistance Programs
DC Medicaid Rx (DC Health Care Alliance)
Prescription drug coverage for DC Medicaid beneficiaries and uninsured DC residents with incomes up to 200% FPL through the DC Health Care Alliance program.
Eligibility: Low-income DC residents including adults up to 215% FPL for Medicaid, and uninsured adults through the Alliance program.
DCPAP (DC Pharmaceutical Assistance Program)
Assists eligible low-income DC seniors with Medicare Part D co-payments and coverage gaps.
Eligibility: DC residents aged 65+ enrolled in Medicare Part D with income at or below 300% FPL. Contact the DC Office on Aging at 202-724-5622.
Frequently Asked Questions
What is cheaper than Wegovy?
Compounded semaglutide can cost $200–$400/month during shortage periods. Zepbound (tirzepatide) may be similarly priced depending on your pharmacy and plan.
Is Ozempic the same as Wegovy?
Both contain semaglutide. Wegovy uses a higher dose (2.4 mg) approved specifically for chronic weight management. Ozempic (0.5–2 mg) is approved for diabetes.
How can Script Unlock help reduce my Wegovy cost?
Script Unlock connects patients to compounding pharmacies and independent pharmacies that may offer competitive pricing on brand Wegovy and compounded semaglutide.